What is the address of DR. KAREN PAUWELYN , gastro-enterologie?

The registered office of DR. KAREN PAUWELYN , gastro-enterologie is located at Hoksentstraat 43, 3940 Hechtel-Eksel.

Is DR. KAREN PAUWELYN , gastro-enterologie still active?

Yes. According to the CBE (18 September 2026) DR. KAREN PAUWELYN , gastro-enterologie is active, legal situation “Normale toestand”, started on 11 September 2013.

Is DR. KAREN PAUWELYN , gastro-enterologie registered on Peppol?

Yes, DR. KAREN PAUWELYN , gastro-enterologie is registered on the Peppol network with ID 0208:0538706128.

What is the enterprise number of DR. KAREN PAUWELYN , gastro-enterologie?

The enterprise number of DR. KAREN PAUWELYN , gastro-enterologie is BE0538706128.

When was DR. KAREN PAUWELYN , gastro-enterologie founded?

DR. KAREN PAUWELYN , gastro-enterologie was founded on 11 September 2013.

Who are the directors of DR. KAREN PAUWELYN , gastro-enterologie?

According to the 2025 annual accounts, the directors of DR. KAREN PAUWELYN , gastro-enterologie are: Karen Pauwelyn.

Is DR. KAREN PAUWELYN , gastro-enterologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 September 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. KAREN PAUWELYN , gastro-enterologie make in 2025?

DR. KAREN PAUWELYN , gastro-enterologie posted a profit after taxes of € 129,943 in financial year 2025.

What is the revenue of DR. KAREN PAUWELYN , gastro-enterologie?

As a small company, DR. KAREN PAUWELYN , gastro-enterologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 198,845.

DR. KAREN PAUWELYN , gastro-enterologie (Private Limited)

Dossier DR. KAREN PAUWELYN , gastro-enterologie, printed on 18 September 2026 from databakkes.be/en/0538706128/dr-karen-pauwelyn-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KAREN PAUWELYN , gastro-enterologie from Hechtel-Eksel, company number BE0538706128, closed financial year 2025 with a result of € 129,943 after tax. For that financial year DR. KAREN PAUWELYN , gastro-enterologie recorded a gross margin of € 198,845 and equity of € 774,374. Compared with financial year 2024, the result moved from € 182,172 to € 129,943. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 774,374

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 129,943

▼ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 103,230

▲ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,000 paid out

42 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 9,922

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,648

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,479

▼ 62% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 146,110 Gross margin 2022: € 146,110 First fiscal year in the series	€ 132,476 Gross margin 2023: € 132,476 ▼ 9% vs 2022 (€ 146,110) Unfavourable step	€ 193,809 Gross margin 2024: € 193,809 ▲ 46% vs 2023 (€ 132,476) Favourable step	€ 198,845 Gross margin 2025: € 198,845 ▲ 3% vs 2024 (€ 193,809) Favourable step	▲ 3%
Profit after taxes	€ 84,078 Profit after taxes 2022: € 84,078 First fiscal year in the series	€ 77,511 Profit after taxes 2023: € 77,511 ▼ 8% vs 2022 (€ 84,078) Unfavourable step	€ 182,172 Profit after taxes 2024: € 182,172 ▲ 135% vs 2023 (€ 77,511) Favourable step	€ 129,943 Profit after taxes 2025: € 129,943 ▼ 29% vs 2024 (€ 182,172) Unfavourable step	▼ 29%
Equity	€ 557,037 Equity 2022: € 557,037 First fiscal year in the series	€ 583,575 Equity 2023: € 583,575 ▲ 5% vs 2022 (€ 557,037) Favourable step	€ 699,431 Equity 2024: € 699,431 ▲ 20% vs 2023 (€ 583,575) Favourable step	€ 774,374 Equity 2025: € 774,374 ▲ 11% vs 2024 (€ 699,431) Favourable step	▲ 11%
Total debts	€ 77,516 Total debts 2022: € 77,516 First fiscal year in the series	€ 66,294 Total debts 2023: € 66,294 ▼ 14% vs 2022 (€ 77,516) Favourable step	€ 65,481 Total debts 2024: € 65,481 ▼ 1% vs 2023 (€ 66,294) Favourable step	€ 91,440 Total debts 2025: € 91,440 ▲ 40% vs 2024 (€ 65,481) Unfavourable step	▲ 40%
Cash	€ 125,176 Cash 2022: € 125,176 First fiscal year in the series	€ 96,418 Cash 2023: € 96,418 ▼ 23% vs 2022 (€ 125,176) Unfavourable step	€ 94,038 Cash 2024: € 94,038 ▼ 2% vs 2023 (€ 96,418) Unfavourable step	€ 103,230 Cash 2025: € 103,230 ▲ 10% vs 2024 (€ 94,038) Favourable step	▲ 10%
Retained profit	€ 544,537 Retained profit 2022: € 544,537 First fiscal year in the series	€ 571,075 Retained profit 2023: € 571,075 ▲ 5% vs 2022 (€ 544,537) Favourable step	€ 686,931 Retained profit 2024: € 686,931 ▲ 20% vs 2023 (€ 571,075) Favourable step	€ 761,874 Retained profit 2025: € 761,874 ▲ 11% vs 2024 (€ 686,931) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 50,973 Dividend 2023: € 50,973 Unchanged (€ 0) Unchanged	€ 66,316 Dividend 2024: € 66,316 ▲ 30% vs 2023 (€ 50,973) Unchanged	€ 55,000 Dividend 2025: € 55,000 ▼ 17% vs 2024 (€ 66,316) Unchanged	▼ 17%
Bank debt	€ 52,511 Bank debt 2022: € 52,511 First fiscal year in the series	€ 24,332 Bank debt 2023: € 24,332 ▼ 54% vs 2022 (€ 52,511) Favourable step	€ 12,222 Bank debt 2024: € 12,222 ▼ 50% vs 2023 (€ 24,332) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 12,222) Favourable step	▼ 100%
Balance sheet total	€ 634,553 Balance sheet total 2022: € 634,553 First fiscal year in the series	€ 649,868 Balance sheet total 2023: € 649,868 ▲ 2% vs 2022 (€ 634,553) Unchanged	€ 764,912 Balance sheet total 2024: € 764,912 ▲ 18% vs 2023 (€ 649,868) Unchanged	€ 865,813 Balance sheet total 2025: € 865,813 ▲ 13% vs 2024 (€ 764,912) Unchanged	▲ 13%

Key figures of DR. KAREN PAUWELYN , gastro-enterologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. KAREN PAUWELYN , gastro-enterologie?

What happened at DR. KAREN PAUWELYN , gastro-enterologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 129,943 (▼ 29% vs 2024). Source: NBB ↗
Sep 11, 2013 New establishment in Hechtel-Eksel. KBO
Sep 11, 2013 Start of the company according to the CBE. KBO

In short

From € 84,078 profit in 2022 to € 129,943 profit in 2025.

Paid € 204,005 in corporate taxes since 2022.

Best year ever: 2024, with € 182,172 profit.

Paid out € 172,289 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. KAREN PAUWELYN , gastro-enterologie? We notify you, reason included.

Follow DR. KAREN PAUWELYN , gastro-enterologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit